HER2 +

Related by string. * Her2 : HER2 positive breast cancer . HER2 positive . HER2 positivity . HER2 negative . HER2 positive metastatic breast . HER2 positive tumors . metastatic HER2 positive / + - [008] . + - [003] . + - [027] . + - [020] . + - [007] . + - [017] . + - [022] : + S europe . + input switcher . Average + -1 . Crispin Porter + Bogusky . diagnosed Ph + . assigned BBB + . Wieden + Kennedy * *

Related by context. Frequent words. (Click for all words.) 68 HER2 positive 65 metastatic colorectal cancer 64 hormone receptor positive 62 metastatic breast cancer 62 estrogen receptor positive 61 NSCLC 61 mCRC 60 metastatic 60 hormone refractory prostate cancer 59 trastuzumab 59 HRPC 59 chronic lymphocytic leukemia CLL 58 HER2 58 docetaxel 58 resistant ovarian cancer 58 hepatocellular carcinoma HCC 58 HER2 positive breast cancer 58 metastatic prostate cancer 58 T DM1 57 adjuvant chemotherapy 57 neoplasia 57 carcinomas 57 advanced NSCLC 57 cetuximab 57 carcinoma 56 BCR ABL 56 endocrine therapy 56 dasatinib 56 adjuvant therapy 56 adenocarcinoma 56 liver metastases 56 soft tissue sarcomas 56 gefitinib 56 brain metastases 56 B CLL 56 unresectable 55 chronic myeloid leukemia CML 55 metastatic disease 55 chemotherapy regimens 55 breast cancers 55 taxane 55 metastatic pancreatic cancer 55 factor receptor 55 Vectibix 55 sunitinib 55 gemcitabine 55 metastatic melanoma 55 MDV# 55 tumor recurrence 55 cell carcinoma 55 cisplatin 54 myelodysplastic syndromes 54 IMGN# 54 bone metastases 54 EGFR 54 vandetanib 54 renal cell carcinoma 54 myelodysplastic syndromes MDS 54 FOLFOX 54 squamous cell 54 capecitabine 54 systemic lupus erythematosus SLE 54 metastatic cancer 54 glioblastoma 54 fludarabine 54 GIST 54 estrogen receptor 54 solid tumors 54 kinase inhibitor 53 bevacizumab 53 lung tumors 53 VIDAZA 53 chemoradiation 53 tumors 53 malignancies 53 Cell Lung Cancer 53 prostate cancers 53 cell lung cancer 53 median PFS 53 lapatinib 53 ovarian cancer 53 resected 53 pancreatic cancers 53 breast tumors 52 sorafenib 52 factor receptor EGFR 52 Docetaxel 52 TREANDA 52 letrozole 52 hepatocellular carcinoma 52 temozolomide 52 follicular lymphoma 52 bortezomib 52 fluorouracil 52 gastric cancer 52 erlotinib 52 ovarian cancers 52 anastrozole 52 cutaneous T cell 52 colorectal cancer 52 invasive bladder

Back to home page